Section Arrow
ILMN.NASDAQ
- Illumina
Quotes are at least 15-min delayed:2026/09/01 22:26 EDT
Regular Hours
Last
 207.13
-6.5 (-3.04%)
Day High 
213.385 
Prev. Close
213.63 
1-M High
231.81 
Volume 
1.50M 
Bid
205
Ask
207.88
Day Low
206.82 
Open
212.36 
1-M Low
186.64 
Market Cap 
32.26B 
Currency 美元 
P/E 39.86 
%Yield -- 
10-SMA 215.59 
20-SMA 204.73 
50-SMA 194.55 
52-W High 231.81 
52-W Low 88 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
5.36/6.18
Enterprise Value
34.23B
Balance Sheet
Book Value Per Share
18.79
Cash Flow
Cash Flow Yield
0.03
Income Statement
Total Revenue
4.58B
Operating Revenue Per Share
29.54
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BIAFbioAffinity Technologies Inc6.59+2.03+44.52%-- 
PSNLPersonalis17.06+0.28+1.67%-- 
DHRDanaher Corp206.93-6.63-3.10%38.07PE
RVTYRevvity126.59-2.08-1.62%61.86PE
OPKOPKO Health1.52+0.05+3.40%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.